Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease.
Miura
M
M
Ohki
H
H
Yoshiba
S
S
Ueda
H
H
Sugaya
A
A
Satoh
M
M
Yamagishi
H
H
D000925:Anticoagulants / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects*; D009080:Mucocutaneous Lymph Node Syndrome / Q000188:drug therapy*; D020551:Pulse Therapy, Drug
D000925:Anticoagulants; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D006493:Heparin; D008775:Methylprednisolone